CA-WORLDLY
21.5.2024 11:01:28 CEST | Business Wire | Press release
Worldly, the leading supply chain sustainability data and insights platform for the consumer goods and apparel industries, today announced the launch of Facility Data Manager (FDM) to help businesses more effectively track ongoing progress towards their decarbonization targets and make decisions that drive environmental improvements faster. As sustainability regulations such as the Corporate Sustainability Reporting Directive (CSRD) emerge globally, FDM helps brands prepare for environmental reporting requirements by providing timely primary data that aligns with regulatory frameworks.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240521428850/en/
As sustainability regulations such as the Corporate Sustainability Reporting Directive (CSRD) emerge globally, Facility Data Manager helps brands prepare for environmental reporting requirements by providing timely primary data that aligns with regulatory frameworks. (Graphic: Business Wire)
Aligned with Cascale’s industry standard Higg Facility Environmental Module (FEM) — the most comprehensive assessment for environmental performance in the consumer goods industry — Worldly’s new Facility Data Manager enables manufacturing facilities to regularly share key impact data with their brand and retail partners. Brands can access quantitative data on energy, water, waste and other impacts submitted by dozens to thousands of manufacturing facilities, as frequently as monthly. With FDM, brands can see the waste, water and emissions they are uniquely responsible for within a single factory. This addresses a critical industry need for more timely, standardized, high-quality primary data and insights for assessing ongoing risks and opportunities for supply chain improvements and reporting sustainability progress.
"We are pleased to introduce Facility Data Manager as a transformative addition to Worldly’s sustainability solutions," says Scott Raskin, CEO of Worldly. “At Worldly, our goal is to help companies make clear, credible progress against their environmental and labor targets while helping them prepare and comply with important evolving regulatory requirements. This requires more actionable data and deeper collaboration between manufacturers and brands. I’m excited about the improved insights and transparency into performance, targets and progress that Facility Data Manager provides, and the new level of partnership that it enables as companies look to accelerate impact across the supply chain.”
Manufacturing facilities that complete the annual Higg FEM assessment can automatically import monthly data from FDM into Higg FEM, reducing reporting time and avoiding redundancy of work. Additionally, within FDM, facilities can track their own sustainability targets and share progress with their brand and retailer partners, enabling a new level of collaboration and transparency across the complex global supply chain.
"Strong communication with our brand partners is essential to our business,” Cecilia Chan, Chief Commercial Officer of Legend Swimwear Factory Limited, said. “Sustainability innovations like this from Worldly deepen our collaboration with brands and make it much easier for us to not only help them meet their environmental targets, but ours as well."
Facility Data Manager has been developed in alignment with the Higg FEM tool established by Cascale (formerly Sustainable Apparel Coalition) in 2011. As the most widely used standardized measurement framework within the apparel and footwear industry, the Higg Index suite of tools is available exclusively on the Worldly platform and used by 350+ brands and 40,000 facilities around the world for measuring environmental and social impact. Cascale will soon begin to engage its members through a governance process to support FDM’s adoption into the Higg Index.
“We welcome the additional data insights and synergistic opportunities provided by Worldly's Facility Data Manager," said Colin Browne, CEO of Cascale, the global nonprofit alliance empowering collaboration to drive equitable and restorative business practices in the consumer goods industry. "FDM integrates seamlessly with Cascale's Higg Facility Environmental Module to provide a clear and transparent picture of environmental impacts and help our members improve sustainability and align with relevant industry standards. It’s exactly what our industry needs to catalyze impact at scale.”
For more information about Facility Data Manager and Worldly's solutions, please visit worldly.io.
About Worldly
Worldly is the planet’s most comprehensive supply chain sustainability data and insights platform, trusted by 40,000+ major brands, retailers and manufacturers in fashion, outdoor, home goods, toys and more. Worldly uniquely collects high-resolution primary data specific to companies’ value chains, operations and products, providing insight into true impacts across carbon, water, chemistry and labor. Featuring the most comprehensive source of ESG data for global manufacturers and the largest library of materials and product impacts, Worldly empowers businesses to scale responsibility into their global operations, faster and more accurately. Hosting, connecting with, and supporting the leading industry solutions and methodologies including ZDHC, Bluesign and the Higg Index – the most widely-adopted measure of sustainability in the consumer goods industry – Worldly delivers the insights businesses need to reduce their impact, comply with emerging regulatory and financial disclosure requirements and meet the expectations of a new generation of customers. www.worldly.io
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240521428850/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
